| 000 | 02783 a2200721 4500 | ||
|---|---|---|---|
| 005 | 20250516001525.0 | ||
| 264 | 0 | _c20101214 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-10-0923 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartinelli, Erika | |
| 245 | 0 | 0 |
_aSynergistic antitumor activity of sorafenib in combination with epidermal growth factor receptor inhibitors in colorectal and lung cancer cells. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cOct 2010 |
||
| 300 |
_a4990-5001 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aBenzenesulfonates _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCell Growth Processes _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aErlotinib Hydrochloride |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHCT116 Cells |
| 650 | 0 | 4 | _aHT29 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 650 | 0 | 4 |
_aQuinazolines _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xbiosynthesis |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aTroiani, Teresa | |
| 700 | 1 | _aMorgillo, Floriana | |
| 700 | 1 | _aRodolico, Gabriella | |
| 700 | 1 | _aVitagliano, Donata | |
| 700 | 1 | _aMorelli, Maria Pia | |
| 700 | 1 | _aTuccillo, Concetta | |
| 700 | 1 | _aVecchione, Loredana | |
| 700 | 1 | _aCapasso, Anna | |
| 700 | 1 | _aOrditura, Michele | |
| 700 | 1 | _aDe Vita, Ferdinando | |
| 700 | 1 | _aEckhardt, S Gail | |
| 700 | 1 | _aSantoro, Massimo | |
| 700 | 1 | _aBerrino, Liberato | |
| 700 | 1 | _aCiardiello, Fortunato | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 16 _gno. 20 _gp. 4990-5001 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-10-0923 _zAvailable from publisher's website |
| 999 |
_c20143635 _d20143635 |
||